Fourth State Medicine Wins a Research Grant from the British Skin Foundation

| News

Triteq client Fourth State Medicine has won a research grant from the British Skin Foundation to continue their research and development of a gas plasma based wound care product. This 3-year grant will focus on looking at how the balance of microbes on the skin can affect the ability of a wound to heal and how plasma can help sterilise against the range of bacteria that can be found within a wound.

The grant fully funds a PhD level study which will be jointly supervised by Dr. Matthew Hardman from the University of Hull and Dr. Thomas Harle, CTO of Fourth State Medicine,. The British Skin Foundation funding has provided access to University of Hull’s excellent facilities and links, accelerating the development of the wound care product.

Fourth State Medicine Profile

Fourth State Medicine (4SM) is an disruptive design and manufactor company seeking to deliver on the promise of biomedical gas plasma technology.  They are currently delivering a new minimally invasive cosmetic surgery product to the cosmetic and aesthetic industry and are developing new wound care products which leverage their proprietary platform plasma technology .

For more information about Fourth State Medicine, please visit their website: https://www.fourthstatemedicine.co.uk/

Leave a Reply

Your email address will not be published. Required fields are marked *

product design & development for:

The Oxford Trust Enterprise Awards 2018!

Award applications open for the 2018 Enterprise Awards The Oxford Trust is pleased to announce that the application process is now open for its prestigious Enterprise Awards 2018. The Oxford Trust Enterprise Awards 2018 take place after Venturefest Oxford on… more

Will China win the global race for complete AI dominance?

According to  China will be the world’s dominant player in artificial intelligence by 2030. This isn’t a prediction by a researcher or academic, it’s government policy from Beijing. A State Council document, issued in July last year, resolved to position… more